A powerful congressional committee is expected to approve a report this week that directs federal officials to take enforcement action against unregulated cannabinoid products that “threaten consumer safety.”
The House Appropriations Committee on Wednesday is set to take up a Fiscal Year 2027 spending bill covering Commerce, Justice, Science, and Related Agencies, as well as an attached report that includes the directive.
It calls on the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to address the “proliferation of Federally unregulated ingestible, inhalable, and topical products that contain intoxicating cannabinoids.”
“Intoxicating Cannabidiols.—The Committee is concerned by the proliferation of Federally unregulated ingestible, inhalable, and topical products that contain intoxicating cannabinoids. The Committee directs the DEA, in coordination with the FDA Office of Inspections and Investigations, to take appropriate enforcement actions against those whose products threaten consumer safety and fail to meet the statutory definition of section 10113 of Public Law 115–334 and section 781 of Public Law 119–37. The Committee further directs the DEA to report on these efforts and any resources necessary to enforce the controlled substance laws and regulations of the United States not later than 90 days after the enactment of this Act.”
While the
Read full article on Marijuana Moment
